These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28705680)

  • 1. Characterization of significant molecular determinants of virulence of Enterovirus 71 sub-genotype B4 in Rhabdomyosarcoma cells.
    Yee PTI; Mohamed RAH; Ong SK; Tan KO; Poh CL
    Virus Res; 2017 Jun; 238():243-252. PubMed ID: 28705680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of molecular determinants of cell culture growth characteristics of Enterovirus 71.
    Yee PT; Tan KO; Othman I; Poh CL
    Virol J; 2016 Nov; 13(1):194. PubMed ID: 27894305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
    Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The untranslated regions of EV-A71 contribute to its pathogenicity and virulence.
    Dong Z; Liu ZW; Chen R; Wen XJ; Ji J; Zheng XX; Zhao L; Wang ZY; Wen HL
    Virus Res; 2019 Apr; 263():55-63. PubMed ID: 30611822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice.
    Yee PTI; Tan SH; Ong KC; Tan KO; Wong KT; Hassan SS; Poh CL
    Sci Rep; 2019 Mar; 9(1):4805. PubMed ID: 30886246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive enterovirus A71 virulence in mice.
    Tee HK; Tan CW; Yogarajah T; Lee MHP; Chai HJ; Hanapi NA; Yusof SR; Ong KC; Lee VS; Sam IC; Chan YF
    PLoS Pathog; 2019 Nov; 15(11):e1007863. PubMed ID: 31730673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine candidates generated by codon and codon pair deoptimization of enterovirus A71 protect against lethal challenge in mice.
    Lee MHP; Tan CW; Tee HK; Ong KC; Sam IC; Chan YF
    Vaccine; 2021 Mar; 39(12):1708-1720. PubMed ID: 33640144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Selective Bottleneck Shapes the Evolutionary Mutant Spectra of Enterovirus A71 during Viral Dissemination in Humans.
    Huang SW; Huang YH; Tsai HP; Kuo PH; Wang SM; Liu CC; Wang JR
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans.
    Meng T; Wong SM; Chua KB
    J Virol; 2021 Oct; 95(22):e0105521. PubMed ID: 34468173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VP1 codon deoptimization and high-fidelity substitutions in 3D polymerase as potential vaccine strategies for eliciting immune responses against enterovirus A71.
    Hsieh W-S; Chao C-H; Shen C-Y; Cheng D; Huang S-W; Wang Y-F; Chen C-C; Chen S-H; Hsu L-J; Wang J-R
    J Virol; 2024 Jan; 98(1):e0155823. PubMed ID: 38174926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model.
    Xu Y; Ma S; Zhu L; Huang Z; Chen L; Xu Y; Yin H; Peng T; Wang Y
    Antiviral Res; 2017 Jan; 137():67-75. PubMed ID: 27864074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enterovirus A71 DNA-Launched Infectious Clone as a Robust Reverse Genetic Tool.
    Tan CW; Tee HK; Lee MH; Sam IC; Chan YF
    PLoS One; 2016; 11(9):e0162771. PubMed ID: 27617744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic evidence for recombination and mutation in the emergence of human enterovirus 71].
    Liu AP; Tan H; Xie Q; Chen BT; Liu XF; Zhang Y
    Bing Du Xue Bao; 2014 Sep; 30(5):572-8. PubMed ID: 25562969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology.
    Yang YT; Chow YH; Hsiao KN; Hu KC; Chiang JR; Wu SC; Chong P; Liu CC
    Antiviral Res; 2016 Aug; 132():225-32. PubMed ID: 27387826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single Mutation in the VP1 of Enterovirus 71 Is Responsible for Increased Virulence and Neurotropism in Adult Interferon-Deficient Mice.
    Caine EA; Moncla LH; Ronderos MD; Friedrich TC; Osorio JE
    J Virol; 2016 Oct; 90(19):8592-604. PubMed ID: 27440896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral determinants that drive Enterovirus-A71 fitness and virulence.
    Ang PY; Chong CWH; Alonso S
    Emerg Microbes Infect; 2021 Dec; 10(1):713-724. PubMed ID: 33745413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the EV-A71 Genome through Recombination and Spontaneous Mutations: Impact on Virulence.
    Mandary MB; Poh CL
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29895721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Plaque Variants and the Involvement of Quasi-Species in a Population of EV-A71.
    Mandary MB; Masomian M; Ong SK; Poh CL
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32560288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of genetic changes, pathogenicity and antigenicity on Enterovirus- A71 vaccine development.
    Yee PTI; Laa Poh C
    Virology; 2017 Jun; 506():121-129. PubMed ID: 28384566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterovirus A71: virulence, antigenicity, and genetic evolution over the years.
    Huang SW; Cheng D; Wang JR
    J Biomed Sci; 2019 Oct; 26(1):81. PubMed ID: 31630680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.